AI Article Synopsis

  • SAMHD1, a protein with nucleotidase activity, restricts HIV-1 in myeloid cells by depleting free nucleotides, thereby inhibiting reverse transcription; however, the Vpx protein from HIV-2 and some SIVs can counteract SAMHD1's effects.
  • Type I interferons can enhance the transcription of SAMHD1, with observed increases during the acute phase of SIV infection in the CNS, although the levels decrease during quieter phases but generally remain elevated post-infection.
  • In vitro studies show that SAMHD1 is highly expressed in macaque astrocytes and is further induced by interferon, suggesting a potential role in restricting retroviruses in

Article Abstract

Restriction of HIV-1 in myeloid-lineage cells is attributed in part to the nucleotidase activity of the SAM-domain and HD-domain containing protein (SAMHD1), which depletes free nucleotides, blocking reverse transcription. In the same cells, the Vpx protein of HIV-2 and most SIVs counteracts SAMHD1. Both Type I and II interferons may stimulate SAMHD1 transcription. The contributions of SAMHD1 to retroviral restriction in the central nervous system (CNS) have been the subject of limited study. We hypothesized that SAMHD1 would respond to interferon in the SIV-infected CNS but would not control virus due to SIV Vpx. Accordingly, we investigated SAMHD1 transcript abundance and association with the Type I interferon response in an SIV model. SAMHD1 transcript levels were IFN responsive, increasing during acute phase infection and decreasing during a more quiescent phase, but generally remaining elevated at all post-infection time points. In vitro, SAMHD1 transcript was abundant in macaque astrocytes and further induced by Type I interferon, while IFN produced a weaker response in the more permissive environment of the macrophage. We cannot rule out a contribution of SAMHD1 to retroviral restriction in relatively non-permissive CNS cell types. We encourage additional research in this area, particularly in the context of HIV-1 infection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776177PMC
http://dx.doi.org/10.1038/srep22629DOI Listing

Publication Analysis

Top Keywords

samhd1 transcript
16
samhd1
10
central nervous
8
nervous system
8
samhd1 retroviral
8
retroviral restriction
8
type interferon
8
transcript upregulation
4
upregulation siv
4
siv infection
4

Similar Publications

Article Synopsis
  • Heavy metal pollution in aquaculture ponds, especially from cadmium and copper, threatens aquatic life and human health by accumulating in the food chain.
  • Bioremediation is presented as a viable solution, where specific organisms help absorb and reduce heavy metal contamination.
  • A study on the freshwater clam Corbicula fluminea showed that exposure to these metals resulted in significant accumulation and adverse effects on the clam's health, indicating its potential use in mitigating heavy metal pollution in aquaculture.
View Article and Find Full Text PDF

Dasatinib interferes with HIV-1 proviral integration and the inflammatory potential of monocyte-derived macrophages from people with HIV.

Biochem Pharmacol

November 2024

Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain. Electronic address:

Article Synopsis
  • * Dasatinib, a medication used for chronic myeloid leukemia, shows promise against HIV-1 by preserving the antiviral activity of the SAMHD1 protein in CD4+ T cells and reducing the phosphorylation that inactivates it, inhibiting HIV-1 infection in macrophages.
  • * Short-term dasatinib treatment lowers inflammatory cytokines in macrophages while maintaining some antiviral responses, suggesting that combining dasatinib with ART could effectively target HIV-1 reservoirs and reduce inflammation in people living with HIV.
View Article and Find Full Text PDF

Hypoxia drives HIF2-dependent reversible macrophage cell cycle entry.

Cell Rep

July 2024

Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK; Africa Health Research Institute, Durban, KwaZulu Natal, South Africa. Electronic address:

Low-oxygen conditions (hypoxia) have been associated primarily with cell-cycle arrest in dividing cells. Macrophages are typically quiescent in G0 but can proliferate in response to tissue signals. Here we show that hypoxia (1% oxygen tension) results in reversible entry into the cell cycle in macrophages.

View Article and Find Full Text PDF

Retinoic acid enhances HIV-1 reverse transcription and transcription in macrophages via mTOR-modulated mechanisms.

Cell Rep

July 2024

Département de microbiologie, infectiologie et immunologie, Faculté de médecine, Université de Montréal, Montréal, QC, Canada; Centre de recherche du centre hospitalier de l'Université de Montréal (CR-CHUM), Montréal, QC, Canada. Electronic address:

The intestinal environment facilitates HIV-1 infection via mechanisms involving the gut-homing vitamin A-derived retinoic acid (RA), which transcriptionally reprograms CD4 T cells for increased HIV-1 replication/outgrowth. Consistently, colon-infiltrating CD4 T cells carry replication-competent viral reservoirs in people with HIV-1 (PWH) receiving antiretroviral therapy (ART). Intriguingly, integrative infection in colon macrophages, a pool replenished by monocytes, represents a rare event in ART-treated PWH, thus questioning the effect of RA on macrophages.

View Article and Find Full Text PDF

Toxoplasma gondii (T. gondii) is an obligate intracellular parasite of warm-blooded vertebrates. At present, High-throughput RNA sequencing analysis have made it possible to determine the role of effective genes in host immune response.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!